170 related articles for article (PubMed ID: 8490473)
1. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.
Booy R; Hodgson S; Griffiths H; Chapel HM; Moxon ER
BMJ; 1993 Apr; 306(6883):971-2. PubMed ID: 8490473
[No Abstract] [Full Text] [Related]
2. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
[No Abstract] [Full Text] [Related]
3. [When should vaccination against Haemophilus influenzae type b take place?].
Stickl HA
Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
[No Abstract] [Full Text] [Related]
4. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
[TBL] [Abstract][Full Text] [Related]
5. [Vaccination against Haemophilus influenzae].
Huber EG
Padiatr Padol; 1991; 26(4):203-4. PubMed ID: 1749631
[No Abstract] [Full Text] [Related]
6. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
Claesson BA; Schneerson R; Trollfors B; Lagergård T; Taranger J; Robbins JB
J Pediatr; 1990 Jun; 116(6):929-31. PubMed ID: 2348298
[No Abstract] [Full Text] [Related]
7. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
8. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
[No Abstract] [Full Text] [Related]
9. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G
J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061
[No Abstract] [Full Text] [Related]
10. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
[No Abstract] [Full Text] [Related]
11. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
Wenger JD; Ward JI; Broome CV
Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
[No Abstract] [Full Text] [Related]
12. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS
N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315
[TBL] [Abstract][Full Text] [Related]
13. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
14. Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents.
Kristensen K
Scand J Infect Dis; 1992; 24(5):629-32. PubMed ID: 1465581
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae B immunisation.
Drug Ther Bull; 1993 Jan; 31(1):1-2. PubMed ID: 8440158
[No Abstract] [Full Text] [Related]
16. From the Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
JAMA; 1993 May; 269(18):2359. PubMed ID: 8479054
[No Abstract] [Full Text] [Related]
17. Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
Claesson BA; Trollfors B; Anderson PW; Johansson J; Taranger J; Schneerson R; Robbins JB
Pediatr Infect Dis J; 1996 Feb; 15(2):170-2. PubMed ID: 8822293
[No Abstract] [Full Text] [Related]
18. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.
Booy R; Taylor SA; Dobson SR; Isaacs D; Sleight G; Aitken S; Griffiths H; Chapel H; Mayon-White RT; Macfarlane JA
Arch Dis Child; 1992 Apr; 67(4):475-8. PubMed ID: 1580674
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
Weinberg GA; Granoff DM
Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
[No Abstract] [Full Text] [Related]
20. Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type B vaccine.
Rowe JE; Messinger IK; Schwendeman CA; Popejoy LA
Mil Med; 1990 Oct; 155(10):483-6. PubMed ID: 2122290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
